10th JBF Symposium

This event will cover multidisciplinary topics on not only regulated bioanalysis but also cutting-edge technologies. We are expecting approximately 250 attendees from the academic, industry and regulatory areas.  Preliminary program includes but not limited to: Harmonization of bioanalytical method validation, Validation of biomarker determination, Bioanalysis of antibody drug, New analytical technologies and Collaboration sessions with related organizations. Outcomes and recommendations from JBF Discussion Groups will also be presented.